表紙
市場調查報告書
商品編碼
977381

mRNA疫苗全球市場分析(2021-2031):按治療藥物類型,按mRNA疫苗類型,按用途,按最終用戶,按疫苗類型,按主要國家/地區/主要國家預測,主要mRNA公司資料

mRNA Vaccines Market Report 2021-2031: Forecasts by Treatment Type, by Type mRNA Vaccines, by Application, by End-user, by Vaccine Type, Analysis of Leading Regional/National Markets, Analysis of Leading mRNA Companies

出版日期: | 出版商: Visiongain Ltd | 英文 467 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告分析了全球mRNA疫苗市場,並提供了產品概述,市場的基本結構/最新情況,主要的促進/抑制因素以及估計/預測的市場規模(未來11年),治療藥物,mRNA疫苗,用途,最終用戶,疫苗類型,地區,主要國家的詳細趨勢,主要公司的概況,COVID-19的影響情景等。

目錄

第1章分析概述

第2章執行摘要

  • 按行業劃分的市場考慮
  • 新型冠狀病毒感染(COVID-19)對mRNA疫苗市場的影響

第3章mRNA疫苗概述

  • mRNA疫苗的概念和形式
  • 高效工程mRNA
  • 利與弊
  • mRNA疫苗預防傳染病
  • mRNA疫苗的遞送途徑和製劑
  • mRNA疫苗誘導的免疫應答機制

第4章mRNA疫苗管道

  • mRNA疫苗的優缺點(以及與DNA疫苗的比較)

第5章COVID-19疫苗的研發概述

  • COVID-19疫苗候選藥物的最新趨勢(2020年4月20日)

第6章市場動態

  • 疫苗的重要性
  • 對mRNA疫苗的需求
  • 增加的抗生素耐藥性
  • 當前市場狀況
  • 開發和推出新疫苗的必需品
  • 促進研發(mRNA疫苗)的效果
  • 新興市場需求擴大的原因
  • mRNA疫苗高價對增長率的影響
  • 政府努力對mRNA疫苗銷售的影響
  • 改善獲得可持續免疫服務的好處
  • 可能影響疫苗銷售的經濟因素
  • 通過提供疫苗抑制市場增長
  • 全球市場融資趨勢
  • 技術進步對疫苗市場的影響(例如快速生產)
  • 由於mRNA疫苗管理的高昂價格,抑制了廣泛使用

第7章全球mRNA疫苗市場的趨勢和預測

  • 從COVID-19的影響進行恢復分析(V形/U形/W形/L形恢復)
  • 按區域的恢復分析(V形/U形/W形/L形恢復)
  • 按治療藥物類型進行的恢復分析(V形/U形/W形/L形恢復)
  • 按mRNA類型進行回收率分析(V形/U形/W形/L形回收)
  • 應用回收率分析(V形/U形/W形/L形回收)
  • 最終用戶的恢復分析(V形/U形/W形/L形恢復)
  • 按疫苗類型進行的回收率分析(V型/U型/W型/L型回收)

第8章北美mRNA疫苗市場的趨勢和預測

  • 市場規模(基於價值):從COVID-19的影響中進行的恢復分析
  • 市場規模(國家/地區):從COVID-19的影響中進行的恢復分析
    • 美國市場
    • 加拿大市場
  • 按治療藥物類型進行的恢復分析(V形/U形/W形/L形恢復)
  • 按mRNA類型進行回收率分析(V形/U形/W形/L形回收)
  • 應用回收率分析(V形/U形/W形/L形回收)
  • 最終用戶的恢復分析(V形/U形/W形/L形恢復)
  • 按疫苗類型進行的回收率分析(V型/U型/W型/L型回收)

第9章歐洲mRNA疫苗市場的估計和預測

  • 市場規模(國家/地區):從COVID-19的影響中進行的恢復分析
    • 俄羅斯市場
    • 德國市場
    • 英國市場
    • 法國市場
    • 義大利市場
    • 其他歐洲國家的市場

第十章亞太地區mRNA疫苗市場的趨勢和預測

  • 市場規模(國家/地區):從COVID-19的影響中進行的恢復分析
    • 中國市場
    • 日本市場
    • 印度市場
    • 韓國市場
    • 澳大利亞市場
    • 亞太其他國家/地區的市場

第11章中東和非洲的mRNA疫苗市場的趨勢和預測

  • 市場規模(國家/地區):從COVID-19的影響中進行的恢復分析
    • 土耳其市場
    • 沙特阿拉伯市場
    • 南非市場
    • 伊朗市場
    • 阿拉伯聯合酋長國(UAE)市場
    • 其他中東和非洲國家的市場

第12章拉丁美洲mRNA疫苗市場的估計和預測

  • 市場規模(國家/地區):從COVID-19的影響中進行的恢復分析
    • 巴西市場
    • 墨西哥市場
    • 其他拉丁美洲國家的市場

第13章公司簡介

  • AstraZeneca Pharmaceutical Company
    • 業務概述
    • 財務分析:概述
    • 主要產品/服務
    • 最新趨勢
  • Bausch Health Companies Inc.
  • Bayer Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG.
  • Genentech Biotechnology Company
  • Merck & Co. Pharmaceutical Company
  • Metropolis Healthcare Ltd Clinical Laboratory Company
  • Moderna Biotechnology Company.
  • Mymetics Corporation Company.
  • Open Monoclonal Technology, Inc. (Ligand Pharmaceuticals)
  • Pfizer Pharmaceutical Company.
  • Sanofi Pasteur Pharmaceutical Company.
  • Vertex Biopharmaceutical Company.
  • Virbac Pharmaceutical Company.

第14章結論/建議

第15章詞彙表

目錄
Product Code: PHA0929

Title:
mRNA Vaccines Market Report 2021-2031
Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement, Other), by End-user (Hospitals and Clinics, Research Organizations, Other End-user), by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines, Other Vaccine Types). Plus Analysis of Leading Regional and National Markets and Analysis of Leading mRNA Companies.

mRNA vaccines are key in this COVID-19 pandemic situation?

Vaccines are crucial now. The race for a COVID-19 vaccine is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. The ability to mimic the natural viral infection and therefore produce the antigen proteins from within the cell is seen by many as the best form of protection from this novel coronavirus.

But this isn't the only mRNA vaccine being developed. Other key vaccines areas such as cancer, respiratory illness, and HIV etc. are essential opportunities within mRNA vaccine development.

You need to discover how this will impact the market today, and over the next 10 years:

  • Our in-depth, dedicated 460+-page report contains more than 650 tables and diagrams.
  • Delivers best-benefit areas for short- to long-term mRNA vaccine and future prospects
  • Analyses, for you, global, regional and national sales
  • Highlights successful results, trends, changes and revenue projections
  • Tells you how to profit best from mRNA vaccines today.

This report tells you:

  • How key players in the mRNA market are strategically increasing/ decreasing/ holding their positions?
  • What are the funding trends in the mRNA vaccines market?
  • Development scenarios and global confidence regarding mRNA vaccines
  • Technological and structural changes occurring in the vaccine industry and how they effect you
  • Growth assessments within the mRNA vaccines industry during the forecast timeline?

This report is not available to everyone. Just a few of these reports exist. Make sure you get your copy immediately.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

The emergence of a mRNA Vaccine

The mRNA vaccine market is constantly thriving to improve vaccine efficiency and provide better protection each season. Is this possible? Pharma companies tackle novel approaches to vaccine technology, better administration and delivery, plus production of the vaccine. Never has this been more critical - yet never before has it offered you such opportunity for development.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares of your main competitors.
  • Original analyses - this is not available anywhere else
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Product Pipeline Analysis, product profiles and commercial developments.

UNIQUE COVID-19 VARIATIONS - only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 effects the economy.

Discover sales predictions for the world market and submarkets

By Treatment Type

  • Bioengineered Vaccine
  • Gene Therapy
  • Gene Transcription
  • Cell Therapy
  • Monoclonal Antibody
  • Immune System
  • Other Treatment Type

By Type mRNA Vaccines

  • Non-replicating mRNA
  • In-vivo Self-replicating mRNA
  • In-vitro Non-replicating mRNA
  • Other mRNA Type

By Application

  • Cancer
  • Infectious Disease
  • Gene Editing
  • Protein Replacement
  • Other

By End-User

  • Hospitals and Clinics
  • Research Organizations
  • Other End-User

By Vaccine Type

  • Self-amplifying mRNA-based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines
  • Other Vaccine Types

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential. These technologies are the instruments required for the marketing of mRNA vaccines to achieve higher efficacy in people.

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

  • North America:
    • U.S.
    • Canada
  • Europe:
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific:
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America:
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa:
    • Turkey
    • Saudi Arabia
    • Iran
    • South Africa
    • UAE
    • Rest of Middle East & Africa

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

  • North America:
    • U.S.
    • Canada
  • Europe:
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific:
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America:
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa:
    • Turkey
    • Saudi Arabia
    • Iran
    • South Africa
    • UAE
    • Rest of Middle East & Africa

How the mRNA Vaccines Market report helps you?

In summary, our 460+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for mRNA Vaccines Market, forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 14 key national markets - See forecasts for the mRNA Vaccines market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 15 of the major companies involved in the mRNA Vaccines Market.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.,
  • Bayer Inc.
  • Eli Lilly and Company
  • Roche Holding AG (Roche)
  • Genentech, Inc.
  • Merck & Co., Inc.
  • Metropolis Healthcare Limited
  • Moderna, Inc.
  • Mymetics Corporation
  • Ligand Pharmaceuticals Incorporated (Ligand)
  • Pfizer Inc. (Pfizer)
  • Sanofi
  • Vertex Pharmaceuticals Incorporated
  • Virbac Pharmaceutical

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the mRNA Vaccines Market and leading companies. You will find data, trends and predictions.

Buy our report today mRNA Vaccines Market Report 2021-2031: Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement, Other), by End-user (Hospitals and Clinics, Research Organizations, Other End-user), by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines, Other Vaccine Types). Plus Analysis of Leading Regional and National Markets and Analysis of Leading mRNA Companies. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Study Goals and Objectives
  • 1.2 Scope of the Report
  • 1.3 Target Audience
  • 1.4 Why You Should Buy This Report
  • 1.5 How This Report Delivers
  • 1.6 Key Questions Answered by This Analytical Report Include:
  • 1.7 Who is This Report For?
  • 1.8 Methodology
    • 1.8.1 Primary Research
    • 1.8.2 Secondary Research
  • 1.9 Market Evaluation & Forecasting Methodology
  • 1.10 COIVD-19 Impact Recovery Pattern Analysis
    • 1.10.1 V-Shaped Recovery
    • 1.10.2 U-Shaped Recovery
    • 1.10.3 W-Shaped Recovery
    • 1.10.4 L-Shaped Recovery
  • 1.11 Frequently Asked Questions (FAQ)
  • 1.12 Associated Visiongain Reports
  • 1.13 About Visiongain

2. Executive Summary

  • 2.1 Segment Insights
  • 2.2 COVID-19 Impact on mRNA Vaccines Market

3. mRNA Vaccines Overview

  • 3.1 Conception And Forms Of mRNA Vaccines
  • 3.2 Engineered mRNA With Potent Efficiency
  • 3.3 Advantages and Disadvantages
  • 3.4 mRNA Vaccines in The Prevention Of Infectious Disease
  • 3.5 Delivery Route and Formulation Of mRNA Vaccines
  • 3.6 Mechanism of Immune Response Induced by mRNA Vaccines

4. mRNA Vaccines Pipeline

  • 4.1 Advantages and Disadvantages of mRNA Vaccines (and comparison to DNA vaccines).
    • 4.1.1 Advantages:
    • 4.1.2 Disadvantages:

5. COVID-19 Vaccine Research & Development Overview

  • 5.1 DRAFT landscape of COVID-19 candidate vaccines - 20 April 2020

6. Market Dynamics

  • 6.1 How Important Are Vaccines?
  • 6.2 Is mRNA Vaccination in Demand?
  • 6.3 What about Rise of Antibiotic Resistance?
  • 6.4 What is the Current Market Situation?
  • 6.5 What it Takes to Develop and Launch New Vaccines?
  • 6.6 How Increased R&D Efforts Are Impacting mRNA Vaccines
  • 6.7 Why there is Increased Demand from Emerging Markets?
  • 6.8 How High Pricing of mRNA Vaccines Affecting Growth Rate?
  • 6.9 How Government Initiatives are Helpful for mRNA Vaccines Sales?
  • 6.10 How Improving Access to Sustainable Immunization Services will Help?
  • 6.11 Which Economic Factors Influence Vaccine Sales
  • 6.12 How Vaccine Supply is Restraints Market Growth?
  • 6.13 What are the Funding Trends in Global Market?
  • 6.14 How Technological Advancements such as Rapid Manufacturing and Others are Impacting Vaccines Market?
  • 6.15 Is High Cost Associated with mRNA Vaccine Dose to Limit Adoption?

7. Global mRNA Vaccine Market Estimation & Forecast

  • 7.1 COVID Impact Recovery Analysis (V, W, U, L Shape)
  • 7.2 by Region: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 7.3 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 7.4 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 7.5 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 7.6 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 7.7 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

8. North America mRNA Vaccine Market Estimation & Forecast

  • 8.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.3 US Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 8.3.1 US Will Always Have A Secured Access to Abundant Supply Of The Various Vaccines Available On The Market
  • 8.4 Canada Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 8.4.1 Canada Focuses to Increase Awareness Regarding the Value of Vaccines
  • 8.5 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.6 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.7 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.8 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 8.9 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

9. Europe mRNA Vaccine Market Estimation & Forecast

  • 9.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.3 Russia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 9.3.1 Russian Vaccines Market Is Due To See Modest Revenue Growth
  • 9.4 Germany Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 9.4.1 Germany is One of the Leaders in Vaccine Research & Development
  • 9.5 UK Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 9.5.1 The U.K. is one of the major contributors to the vaccine market.
  • 9.6 France Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 9.6.1 France Is One Of The Major Countries To Produce Vaccines
  • 9.7 Italy Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 9.7.1 Economic Situation In Italy Will Be A Real Restricting Factor For Vaccine R&D
  • 9.8 Rest of Europe Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 9.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

10. Asia-Pacific mRNA Vaccine Market Estimation & Forecast

  • 10.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.3 China Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 10.3.1 China Is Expected To See Tremendous Growth Within The Human Vaccines Market
  • 10.4 Japan Market : COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 10.4.1 Amount of Investment for mRNA Vaccine R&D is on the Rise
  • 10.5 India Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 10.5.1 Indian Vaccines Market Holds Great Potential Due To Its Sheer Population
  • 10.6 South Korea Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 10.6.1 Korean Companies Are Stepping Up Efforts To Advance Into The Global Health Market With Korean Vaccines.
  • 10.7 Australia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 10.7.1 Vaccine Manufacturers Are Continuously Harnessing Their Scientific Knowledge and Technologies to Design Safe and Effective Vaccines
  • 10.8 Rest of Asia-Pacific: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 10.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

11. Middle East & Africa mRNA Vaccine Market Estimation & Forecast

  • 11.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.3 Turkey Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.3.1 Governments Will Be More Inclined to Sponsor the Funding of Vaccines
  • 11.4 Saudi Arabia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.4.1 Saudi Arabia's Healthcare Landscape Will Continue To Evolve As The Government Pursues Reforms
  • 11.5 South Africa Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.5.1 Vaccination Coverage Is Low Because Governments Struggle To Deliver Vaccines To The Most Remote Areas
  • 11.6 Iran Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.6.1 The Vaccine Industry Is One of the Most Important Health-Related Industries
  • 11.7 UAE Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.7.1 UAE in Competition to Develop Vaccines for COVID-19
  • 11.8 Rest of MEA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 11.8.1 Middle East and Africa are laggards when it comes to immunization coverage.
  • 11.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 11.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

12. Latin America mRNA Vaccine Market Estimation & Forecast

  • 12.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.3 Brazil Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 12.3.1 The Brazilian Human Vaccines Market Is the Largest in South America
  • 12.4 Mexico Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
    • 12.4.1 Strong Tendency To Increase The Participation Of The Private Sector in Vaccine R&D
  • 12.5 Rest of LA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.6 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.7 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.8 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.9 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
  • 12.10 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)

13. Company Profiles

  • 13.1 AstraZeneca Pharmaceutical Company
    • 13.1.1 Business Overview
    • 13.1.2 Company Financial Profile
    • 13.1.3 Product and Service Offerings
    • 13.1.4 Recent Developments
  • 13.2 Bausch Health Companies Inc.
    • 13.2.1 Business Overview
    • 13.2.2 Company Financial Profile
    • 13.2.3 Product and Service Offerings
    • 13.2.4 Recent Developments
  • 13.3 Bayer Inc.
    • 13.3.1 Business Overview
    • 13.3.2 Company Financial Profile
    • 13.3.3 Product and Service Offerings
    • 13.3.4 Recent Developments
  • 13.4 Eli Lilly and Company
    • 13.4.1 Business Overview
    • 13.4.2 Company Financial Profile
    • 13.4.3 Product and Service Offerings
    • 13.4.4 Recent Developments
  • 13.5 F. Hoffmann-La Roche AG.
    • 13.5.1 Business Overview
    • 13.5.2 Company Financial Profile
    • 13.5.3 Product and Service Offerings
    • 13.5.4 Recent Developments
  • 13.6 Genentech Biotechnology Company
    • 13.6.1 Business Overview
    • 13.6.2 Company Financial Profile
    • 13.6.3 Product and Service Offerings
    • 13.6.4 Recent Developments
  • 13.7 Merck & Co. Pharmaceutical Company
    • 13.7.1 Business Overview
    • 13.7.2 Company Financial Profile
    • 13.7.3 Product and Service Offerings
    • 13.7.4 Recent Developments
  • 13.8 Metropolis Healthcare Ltd Clinical Laboratory Company
    • 13.8.1 Business Overview
    • 13.8.2 Company Financial Profile
    • 13.8.3 Product and Service Offerings
    • 13.8.4 Recent Developments
  • 13.9 Moderna Biotechnology Company.
    • 13.9.1 Business Overview
    • 13.9.2 Company Financial Profile
    • 13.9.3 Product and Service Offerings
    • 13.9.4 Recent Developments
  • 13.10 Mymetics Corporation Company.
    • 13.10.1 Business Overview
    • 13.10.2 Company Financial Profile
    • 13.10.3 Product and Service Offerings
    • 13.10.4 Recent Developments
  • 13.11 Open Monoclonal Technology, Inc. (Ligand Pharmaceuticals)
    • 13.11.1 Business Overview
    • 13.11.2 Company Financial Profile
    • 13.11.3 Product and Service Offerings
    • 13.11.4 Recent Developments
  • 13.12 Pfizer Pharmaceutical Company.
    • 13.12.1 Business Overview
    • 13.12.2 Company Financial Profile
    • 13.12.3 Product and Service Offerings
    • 13.12.4 Recent Developments
  • 13.13 Sanofi Pasteur Pharmaceutical Company.
    • 13.13.1 Business Overview
    • 13.13.2 Company Financial Profile
    • 13.13.3 Product and Service Offerings
    • 13.13.4 Recent Developments
  • 13.14 Vertex Biopharmaceutical Company.
    • 13.14.1 Business Overview
    • 13.14.2 Company Financial Profile
    • 13.14.3 Product and Service Offerings
    • 13.14.4 Recent Developments
  • 13.15 Virbac Pharmaceutical Company.
    • 13.15.1 Business Overview
    • 13.15.2 Company Financial Profile
    • 13.15.3 Product and Service Offerings
    • 13.15.4 Recent Developments

14. Conclusion and Recommendations

  • 14.1 Other Key Player in the Global Market
  • 14.2 List of Organizations Related to mRNA Market

15. Glossary

List of Figures

  • Figure 3.1 Overview of mRNA Vaccines Mechanism
  • Figure 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.6 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.7 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.8 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.9 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.10 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.11 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.12 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.13 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.14 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.15 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.16 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.17 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.18 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.19 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.20 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.21 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.22 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.23 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.24 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.25 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.26 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.27 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.28 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.29 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.30 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 8.31 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 8.32 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 8.33 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 8.34 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 8.35 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.6 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.7 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.8 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.9 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.10 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.11 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.12 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.13 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.14 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.15 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.16 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.17 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.18 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.19 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.20 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.21 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.22 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.23 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.24 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.25 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.26 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.27 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.28 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.29 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.30 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 9.31 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 9.32 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 9.33 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 9.34 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 9.35 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.6 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.7 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.8 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.9 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.10 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.11 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.12 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.13 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.14 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.15 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.16 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.17 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.18 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.19 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.20 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.21 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.22 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.23 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.24 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.25 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.26 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.27 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.28 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.29 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 10.30 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 10.31 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 10.32 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 10.33 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 10.34 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.6 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.7 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.8 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.9 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.10 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.11 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.12 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.13 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.14 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.15 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.16 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.17 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.18 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.19 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.20 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.21 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.22 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.23 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.24 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.25 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.26 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.27 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.28 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.29 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.30 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 11.31 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 11.32 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 11.33 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 11.34 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 11.35 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.6 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.7 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.8 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.9 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.10 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.11 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.12 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.13 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.14 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.15 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.16 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.17 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.18 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.19 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.20 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.21 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.22 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.23 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.24 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.25 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.26 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.27 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.28 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.29 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.30 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 12.31 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
  • Figure 12.32 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
  • Figure 12.33 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
  • Figure 12.34 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
  • Figure 12.35 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
  • Figure 13.1 AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Figure 13.2 AstraZeneca Pharmaceutical Company: Company Operating Income 2015-2019 (US$Mn)
  • Figure 13.3 AstraZeneca Pharmaceutical Company: Company EBITDA 2015-2019 (US$Mn)
  • Figure 13.4 AstraZeneca Pharmaceutical Company: Company Net Income/Loss 2015-2019 (US$Mn)
  • Figure 13.5 Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Figure 13.6 Bausch Health Companies Inc.: Company Operating Income 2015-2019 (US$Mn)
  • Figure 13.7 Bausch Health Companies Inc.: Company EBITDA 2015-2019 (US$Mn)
  • Figure 13.8 Bausch Health Companies Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
  • Figure 13.9 Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Figure 13.10 Bayer Inc.: Company Operating Income 2015-2019 (US$Mn)
  • Figure 13.11 Bayer Inc.: Company EBITDA 2015-2019 (US$Mn)
  • Figure 13.12 Bayer Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
  • Figure 13.13 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Figure 13.14 Eli Lilly and Company: Company Operating Income 2015-2019 (US$Mn)
  • Figure 13.15 Eli Lilly and Company: Company EBITDA 2015-2019 (US$Mn)
  • Figure 13.16 Eli Lilly and Company: Company Net Income/Loss 2015-2019 (US$Mn)
  • Figure 13.17 F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Figure 13.18 F. Hoffmann-La Roche AG: Company Operating Income 2015-2019 (US$Mn)
  • Figure 13.19 F. Hoffmann-La Roche AG: Company EBITDA 2015-2019 (US$Mn)
  • Figure 13.20 F. Hoffmann-La Roche AG: Company Net Income/Loss 2015-2019 (US$Mn)

List of Tables

  • Table 2.1 Global mRNA Vaccines Market Summary Table
  • Table 3.1 Advantages and Disadvantages of Viral Vectored Vaccines, DNA vaccines and RNA vaccines.
  • Table 3.2 Nucleoside modified or non-modified mRNA vaccines against infectious diseases.
  • Table 3.3 Self-amplifying mRNA vaccines against infectious diseases.
  • Table 4.1 AstraZeneca.: Company mRNA Vaccines Pipeline
  • Table 4.2 Bausch Health Pharmaceutical.: Company mRNA Vaccines Pipeline
  • Table 4.3 Lilly.: Company mRNA Vaccines Pipeline
  • Table 4.4 Roche.: Company mRNA Vaccines Pipeline
  • Table 4.5 Merck & Co.: Company mRNA Vaccines Pipeline
  • Table 4.6 Astrazeneca.: Company mRNA Vaccines Pipeline
  • Table 4.7 Astrazeneca.: Company mRNA Vaccines Pipeline
  • Table 4.8 Sanofi Pasteur S.A.: Company mRNA Vaccines Pipeline
  • Table 4.9 Bayer Inc.: Company mRNA Vaccines Pipeline
  • Table 4.10 Mymetics Corporation Company mRNA Vaccines Pipeline
  • Table 4.11 Genentech, Inc: Company mRNA Vaccines Pipeline
  • Table 4.12 Vertex Pharmaceuticals.: Company mRNA Vaccines Pipeline
  • Table 5.1 5 Candidate Vaccines In Clinical Evaluation
  • Table 5.2 71 candidate vaccines in preclinical evaluation
  • Table 6.1 mRNA Vaccine Industry Growth Driving Forces
  • Table 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.6 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.7 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.8 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.9 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.10 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.11 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.12 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.13 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.14 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.15 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.16 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.17 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.18 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.19 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.20 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.21 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.22 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.23 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.24 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.25 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.26 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.27 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.28 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.29 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.30 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.31 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.32 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.33 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.34 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.35 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 8.36 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 8.37 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 8.38 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 8.39 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 8.40 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.6 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.7 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.8 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.9 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.10 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.11 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.12 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.13 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.14 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.15 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.16 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.17 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.18 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.19 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.20 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.21 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.22 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.23 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.24 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.25 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.26 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.27 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.28 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.29 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.30 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.31 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.32 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.33 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.34 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.35 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.36 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.37 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.38 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.39 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.40 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.41 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.42 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.43 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.44 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.45 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.46 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.47 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.48 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.49 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.50 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.51 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.52 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.53 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.54 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.55 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 9.56 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 9.57 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 9.58 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 9.59 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 9.60 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.6 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.7 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.8 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.9 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.10 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.11 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.12 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.13 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.14 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.15 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.16 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.17 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.18 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.19 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.20 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.21 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.22 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.23 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.24 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.25 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.26 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.27 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.28 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.29 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.30 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.31 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.32 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.33 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.34 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.35 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.36 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.37 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.38 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.39 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.40 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.41 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.42 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.43 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.44 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.45 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.46 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.47 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.48 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.49 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.50 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.51 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.52 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.53 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.54 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 10.55 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 10.56 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 10.57 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 10.58 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 10.59 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.6 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.7 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.8 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.9 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.10 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.11 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.12 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.13 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.14 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.15 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.16 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.17 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.18 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.19 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.20 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.21 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.22 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.23 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.24 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.25 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.26 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.27 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.28 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.29 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.30 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.31 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.32 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.33 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.34 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.35 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.36 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.37 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.38 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.39 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.40 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.41 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.42 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.43 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.44 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.45 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.46 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.47 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.48 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.49 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.50 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.51 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.52 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.53 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.54 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.55 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 11.56 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 11.57 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 11.58 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 11.59 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 11.60 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.6 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.7 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.8 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.9 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.10 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.11 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.12 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.13 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.14 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.15 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.21 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.22 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.23 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.24 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.25 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.26 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.27 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.28 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.29 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.30 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.31 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.32 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.33 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.34 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.35 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.36 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.37 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.38 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.39 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.40 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.41 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.42 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.43 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.44 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.45 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 12.46 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
  • Table 12.47 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 12.48 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 12.49 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 12.50 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 13.1 AstraZeneca Pharmaceutical Company: Company Information
  • Table 13.2AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Table 13.3AstraZeneca Pharmaceutical Company: Company Product and Service Offerings
  • Table 13.4AstraZeneca Pharmaceutical Company: Company Recent Developments till July,2020
  • Table 13.5 Bausch Health Companies Inc. Company Information
  • Table 13.6Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Table 13.7Bausch Health Companies Inc.: Company Product and Service Offerings
  • Table 13.8Bausch Health Companies Inc.: Company Recent Developments till July,2020
  • Table 13.9 Bayer Inc. Company Information
  • Table 13.10Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Table 13.11 Bayer Inc.: Company Product and Service Offerings
  • Table 13.12Bayer Inc.: Company Recent Developments till July,2020
  • Table 13.13 Eli Lilly and Company: Company Information
  • Table 13.14 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Table 13.15Eli Lilly and Company: Company Product and Service Offerings
  • Table 13.16Eli Lilly and Company: Company Recent Developments till July,2020
  • Table 13.17F. Hoffmann-La Roche AG Company Information
  • Table 13.18F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
  • Table 13.19F. Hoffmann-La Roche AG: Company Product and Service Offerings
  • Table 13.20F. Hoffmann-La Roche AG: Company Recent Developments till July,2020
  • Table 13.21 Genentech, Inc. Company Information
  • Table 13.22Genentech, Inc.: Company Product and Service Offerings
  • Table 13.23Genentech, Inc.: Company Recent Developments till July,2020

List of Companies Profiled:

  • AstraZeneca PLC
  • Bausch Health Companies Inc.,
  • Bayer Inc.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Ligand Pharmaceuticals Incorporated (Ligand)
  • Merck & Co., Inc.
  • Metropolis Healthcare Limited
  • Moderna, Inc.
  • Mymetics Corporation
  • Pfizer Inc. (Pfizer)
  • Roche Holding AG (Roche)
  • Sanofi
  • Vertex Pharmaceuticals Incorporated
  • Virbac Pharmaceutical

List of Other Companies Mentioned in the Report:

  • Adaptive Biotechnologies Corporation
  • Arcturus Therapeutics Ltd.
  • Argos Therapeutics, Inc.
  • BioNTech AG
  • Bioverativ Inc.
  • Brammer Bio
  • Caperna LLC
  • CELLSCRIPT, LLC
  • CureVac AG
  • Dow AgroSciences LLC
  • Effimune
  • Elpidera LLC
  • eTheRNA immunotherapies NV
  • ethris GmbH
  • Genevant Sciences
  • In-Cell-Art
  • Institut Pasteur
  • Kite Pharma, Inc.
  • MAB Discovery GmbH
  • Mymetics BV
  • Okinawa Health Biotechnology Research and Development Center
  • PCI Biotech
  • Personalis, Inc.
  • Pharmaceutical Product Development, LLC (PPD)
  • Sangamo Therapeutics, Inc.
  • Shire International GmbH
  • Shuwen Biotech Co. Ltd.
  • Sigma-Aldrich Corporation
  • Tiba Biotech LLC
  • Translate Bio, Inc.
  • TxCell, SA
  • Valeant Pharmaceuticals International Inc.
  • Valera LLC

List of Organizations Mentioned in the Report:

  • American Cancer Society (ACS)
  • American Diabetes Organization (ADO)
  • Bill & Melinda Gates Foundation
  • Biomedical Advanced Research and Development Authority (BARDA)
  • Cancer Research UK
  • Defense Advanced Research Projects Agency
  • Friedrich-Loeffler-Institute
  • Institute of Immunology of the Centre de Recherche Public-Santé (CRP)
  • Karolinska Institutet
  • Karolinska University Hospital (KUH)
  • The Coalition for Epidemic Preparedness Innovations (CEPI)
  • U.S. Food and Drug Administration (FDA)
  • University of Pennsylvania (Penn)
  • World Health Organization (WHO)